Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Recruiting
Phase 1
Interventional Study
Major Depressive Disorder
Depression
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 21 – 65
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 10 (estimated)
- Sponsor
- Yale University · Other
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The goal of this fixed order, open-label, dose-escalation study is to investigate the safety and efficacy of specific doses of dimethyltryptamine (DMT) in humans.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Healthy controls inclusion criteria:
* Medically healthy
* Psychiatrically healthy
Healthy controls exclusion criteria:
* Unstable medical conditions
* Psychiatric illness
Depression inclusion criteria:
* Medically healthy
* Diagnosis of major depressive disorder
Depression exclusion criteria:…
Contacts